The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B-Reference-Cited by-同舟云学术

The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B

Published:2016-04 Issue:16 Volume:95 Page:e3372
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Qiang,Song Jie,Huang Yuxian,Li Xinyan,Zhuo Qibin,Li Weixia,Chen Chong,Lu Chuan,Qi Xun,Chen Liang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992–2006: a mathematical model analysis;Liang;J Theor Biol,2015

2. Estimation of cancer burden attributable to infection in Asia;Huang;J Epidemiol,2015

3. Noninvasive evaluation of liver fibrosis using real-time tissue elastography and transient elastography (FibroScan);Meng;J Ultrasound Med,2015

4. Acoustic radiation force impulse elastography, FibroScan®, Forns’ index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods;Dong;Mol Med Rep,2015

5. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B;Jia;J Gastroenterol Hepatol,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Assessment of Two Transferase-Based Liver Enzymes in Low- and High-Fibrosis Patients Chronically Infected with Hepatitis B Virus: A Meta-Analysis and Pilot Study;Journal of Clinical Medicine;2024-07-03

2. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease;Journal of Gastroenterology and Hepatology;2024-07

3. The non-invasive serum biomarkers contributes to indicate liver fibrosis staging and evaluate the progress of chronic hepatitis B;BMC Infectious Diseases;2024-06-26

4. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline;Hepatology;2024-03-15

5. Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B;Cureus;2023-01-13